Patient-derived organoids as a potential model to predict response to PD-1/PD-L1 checkpoint inhibitors

Selection of cancer patients for treatment with immune checkpoint inhibitors remains a challenge due to tumour heterogeneity and variable biomarker detection. PD-L1 expression in 24 surgical chordoma specimen was determined immunohistochemically with antibodies 28-8 and E1L3N. The ability of patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Scognamiglio, Giosue, De Chiara, Annarosaria, Parafioriti, Antonina, Armiraglio, Elisabetta, Fazioli, Flavio, Gallo, Michele, Aversa, Laura, Camerlingo, Rosa, Cacciatore, Francesco, Colella, Gianluca, Pili, Roberto, de Nigris, Filomena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889147/
https://www.ncbi.nlm.nih.gov/pubmed/31666667
http://dx.doi.org/10.1038/s41416-019-0616-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889147/
https://www.ncbi.nlm.nih.gov/pubmed/31666667
http://dx.doi.org/10.1038/s41416-019-0616-1

Ejemplares similares